Optimized Cyclophosphamide (CY) Dosing in Combination with Fludarabine, TBI and ATG As Conditioning for Unrelated Donor Bone Marrow Transplantation (BMT) in Severe Aplastic Anemia (SAA): A Phase I/II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

被引：0
|
作者：
Anderlini, Paolo [1 ]
Wu, Juan [1 ]
Deeg, H. Joachim [1 ]
Gersten, Iris [1 ]
Ewell, Marian [1 ]
Tolar, Jakub [1 ]
Antin, Joseph H. [1 ]
Arai, Sally [1 ]
Horwitz, Mitchell E. [1 ]
McCarty, John M. [1 ]
Nakamura, Ryotaro [1 ]
Pulsipher, Michael A. [1 ]
Adams, Roberta H. [1 ]
Leifer, Eric [1 ]
Carter, Shelly L. [1 ]
DiFronzo, Nancy L. [1 ]
Horowitz, Mary M. [1 ]
Confer, Dennis L. [1 ]
Eapen, Mary [1 ]
机构：
[1] Blood & Marrow Transplant Clin Trials Network, Milwaukee, WI USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 44 条
  • [21] PHASE II TRIAL OF NON-MYELOABLATIVE CONDITIONING (NST) DOUBLE UMBILICAL CORD BLOOD TRANSPLANTATION (DUCBT) FROM UNRELATED DONORS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES: RESULTS OF BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK (BMT CTN) PROTOCOL 0604
    Brunstein, C. G.
    Carter, S.
    Fuchs, E. J.
    Karanes, C.
    Devine, S.
    Aljitawi, O.
    Cutler, C.
    Ballen, K. K.
    Thompson, J.
    O'Donnell, P., V
    Eapen, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S151 - S151
  • [22] Recommendations for Donor Human Leukocyte Antigen Assessment and Matching for Allogeneic Stem Cell Transplantation: Consensus Opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
    Howard, C. Alan
    Fernandez-Vina, Marcelo A.
    Appelbaum, Frederick R.
    Confer, Dennis L.
    Devine, Steven M.
    Horowitz, Mary M.
    Mendizabal, Adam
    Laport, Ginna G.
    Pasquini, Marcelo C.
    Spellman, Stephen R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (01) : 4 - 7
  • [23] A Phase II Trial to Compare Allogeneic Transplant Vs. Standard of Care for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Protocol 1503
    Eapen, Mary
    Neuberg, Donna S.
    Mendizabal, Adam M.
    Stevenson, Kristen E.
    Antin, Joseph H.
    DiFronzo, Nancy
    El Rassi, Fuad A.
    Lulla, Premal
    Waller, Edmund K.
    Garrison, Jamie
    Smith, Shannon
    Sullivan, Keith
    Walters, Mark C.
    Krishnamurti, Lakshmanan
    BLOOD, 2019, 134
  • [24] Easy-to-Read Informed Consent (ETRIC) Form for Hematopoietic Cell Transplantation (HCT) Clinical Trials: Results from Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 1205 Study
    Majhail, Navneet S.
    Tarima, Sergey
    Denzen, Ellen
    Moore, Heather
    Abhyankar, Sunil
    Dawson, Peter
    Foley, Amy
    Gersten, Iris D.
    Horwitz, Mitchell E.
    Idossa, Lensa
    Joffe, Steven
    Kamani, Naynesh
    King, Roberta
    Lazaryan, Aleksandr
    Morris, Lawrence E.
    Horowitz, Mary M.
    Spellecy, Ryan
    BLOOD, 2017, 130
  • [25] Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation
    J C Marsh
    R M Pearce
    M B C Koh
    Z Lim
    A Pagliuca
    G J Mufti
    J Perry
    J A Snowden
    A J Vora
    R T Wynn
    N Russell
    B Gibson
    M Gilleece
    D Milligan
    P Veys
    S Samarasinghe
    M McMullin
    K Kirkland
    G Cook
    Bone Marrow Transplantation, 2014, 49 : 42 - 48
  • [26] Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation
    Marsh, J. C.
    Pearce, R. M.
    Koh, M. B. C.
    Lim, Z.
    Pagliuca, A.
    Mufti, G. J.
    Perry, J.
    Snowden, J. A.
    Vora, A. J.
    Wynn, R. T.
    Russell, N.
    Gibson, B.
    Gilleece, M.
    Milligan, D.
    Veys, P.
    Samarasinghe, S.
    McMullin, M.
    Kirkland, K.
    Cook, G.
    BONE MARROW TRANSPLANTATION, 2014, 49 (01) : 42 - 48
  • [27] Exercise and Stress Management Training For Patients Undergoing Autologous Or Allogeneic Hematopoietic Cell Transplantation. Results From Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902
    Lee, Stephanie J.
    Le Rademacher, Jennifer
    Jim, Heather
    Syrjala, Karen L.
    Wingard, John R.
    Logan, Brent R.
    Wu, Juan
    Majhail, Navneet S.
    Wood, William A.
    Rizzo, J. Douglas
    Geller, Nancy L.
    Kitko, Carrie L.
    Faber, Edward A., Jr.
    Abidi, Muneer H.
    Slater, Susan E.
    Horowitz, Mary M.
    Jacobsen, Paul
    BLOOD, 2013, 122 (21)
  • [28] Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)
    Smith, Eileen P.
    Li, Hongli
    Friedberg, Jonathan W.
    Constine, Louis S.
    Rimsza, Lisa M.
    Cook, James R.
    Laport, Ginna G.
    Popplewell, Leslie L.
    Holmberg, Leona A.
    Smith, Sonali M.
    LeBlanc, Michael
    Forman, Stephen J.
    Fisher, Richard I.
    Stiff, Patrick J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 700 - 707
  • [29] Fludarabine-Based Conditioning for Marrow Transplantation from Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose Deescalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels
    Tolar, Jakub
    Deeg, H. Joachim
    Arai, Sally
    Horwitz, Mitchell
    Antin, Joseph H.
    McCarty, John M.
    Adams, Roberta H.
    Ewell, Marian
    Leifer, Eric S.
    Gersten, Iris D.
    Carter, Shelly L.
    Horowitz, Mary M.
    Nakamura, Ryotaro
    Pulsipher, Michael A.
    DiFronzo, Nancy L.
    Confer, Dennis L.
    Eapen, Mary
    Anderlini, Paolo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (07) : 1007 - 1011
  • [30] Phase I/II study of granulocyte transfusions from G-CSF-stimulated unrelated donors for treatment infections in neutropenic blood and marrow transplant (BMT) patients.
    Bowden, R
    Price, T
    Boeckh, M
    Liles, C
    Cays, M
    Gale, D
    BLOOD, 1997, 90 (10) : 1930 - 1930
12345